Yves Guminski

USPTO Granted Patents = 14 (Patent Applications = 2)

CIPO Patents = 3

EPO Patents = 10 (Patent Applications = 8)

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 15(Granted Patents)

Company Filing History:

13 out of 266

Pierre Fabre Medicament

patents

2 out of 5,069

Centre National De La Recherche Scientifique

patents

1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2016

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9439982 - Fluorescent cyanine-polyamine derivatives as a diagnostic probe (2016-09-13),

2. 9403840 - (Poly) aminoacetamide derivatives of epipodophyllotoxin their process of preparation and their applications in therapeutics as anticancer agents (2016-08-02),

3. 9216989 - (Poly) aminoacetamide derivatives of epipodophyllotoxin their process of preparation and their applications in therapeutics as anticancer agents (2015-12-22),

4. 8785424 - ngCycloartanone derivatives with anticancer activity (2014-07-22),

5. 8664409 - Process for the preparation of (poly) aminoalkylaminoacetamide derivatives of epipodophyllotoxin useful for their applications in therapeutics as anticancer agent (2014-03-04),

6. 8569011 - Fluorescent derivatives of polyamines, method for preparing same and applications thereof as diagnosis tools in the treatment of cancerous tumors (2013-10-29),

7. 8492567 - (Poly)Aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agents (2013-07-23),

8. 8288567 - (Poly) aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agents (2012-10-16),

9. 8193379 - Method for preparing 4B-amino-4'-demethyl-4-desoxypodophyllotoxin (2012-06-05),

10. 8148552 - Process for the synthesis of anticancer (poly) aminoalkylaminoacetamide derivatives of epipodophyllotoxin (2012-04-03),

11. 7932406 - Method for preparing 4β-amino-4'-demethyl-4-desoxypodophyllotoxin (2011-04-26),

12. 7846926 - (Poly)aminoacetamide derivatives of epipodophyllotoxin their process of preparation and their applications in therapeutics as anticancer agents (2010-12-07),

13. 6107284 - Water-soluble derivatives of epipodophyllotoxin, process for their (2000-08-22),

14. 6008382 - Method for preparing 4'-Demethylepipodophyllotoxin from podophyllotoxin (1999-12-28),

Title: Yves Guminski: Innovator in Cancer Diagnostics and Therapeutics

Introduction

Yves Guminski is a prominent inventor based in Lagarrigue, France, known for his significant contributions to the field of cancer diagnostics and therapeutics. With a total of 14 patents to his name, Guminski has made remarkable strides in developing innovative solutions for cancer detection and treatment.

Latest Patents

Among his latest patents, Guminski has developed fluorescent cyanine-polyamine derivatives that serve as diagnostic probes. This invention relates to fluorescent derivatives of cyanines conjugated with a polyamine group, which can be utilized for the detection of cancer tumors, particularly in vivo. Another notable patent involves (poly) aminoacetamide derivatives of epipodophyllotoxin, which are designed as anticancer agents. This invention focuses on novel podophyllotoxin derivatives that are substituted in the 4-position by a (poly)aminoalkylaminoacetamide chain, highlighting their therapeutic potential.

Career Highlights

Throughout his career, Yves Guminski has worked with esteemed organizations such as Pierre Fabre Medicament and the Centre National de la Recherche Scientifique. His work in these institutions has allowed him to advance his research and contribute to the development of innovative medical solutions.

Collaborations

Guminski has collaborated with notable professionals in his field, including Thierry Imbert and Jean-Marc Barret. These partnerships have further enriched his research and innovation efforts.

Conclusion

Yves Guminski's work exemplifies the impact of innovation in the medical field, particularly in cancer diagnostics and therapeutics. His patents and collaborations reflect a commitment to advancing healthcare solutions that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.